Docsity
Docsity

Prepare for your exams
Prepare for your exams

Study with the several resources on Docsity


Earn points to download
Earn points to download

Earn points by helping other students or get them with a premium plan


Guidelines and tips
Guidelines and tips

Biostatistics Exercises and Questions: A Guide to Understanding Health Data, Exams of Nursing

A series of exercises and questions designed to reinforce understanding of key biostatistical concepts. It covers topics such as measures of central tendency, dispersion, incidence, prevalence, and study designs. The exercises are presented in a clear and concise manner, making them suitable for both university and high school students studying biostatistics or related fields.

Typology: Exams

2024/2025

Available from 01/19/2025

smart-scores
smart-scores 🇺🇸

5

(2)

6.8K documents

1 / 8

Toggle sidebar

This page cannot be seen from the preview

Don't miss anything!

bg1
Which |of |the |following |types |of |graphics |would |be |most |useful |in
|demonstrating |the |frequency |of |a |given |outcome |as |it |relates |to |an |ordinal
|variable? |- |correct |answer |histogram
5 |7 |6 |9 |4 |1 |2 |2
According |to |the |data, |which |measure, |is |a |better |measure |of |dispersion? |-
|correct |answer |standard |deviation
Misclassification |bias |often |occurs |in |case-control |studies. |- |correct |answer
|True
The |incidence |rate |of |X |disease |in |patients |receiving |the |new |medication |is
|calculated |by: |- |correct |answer |patients |who |are |receiving |the |new
|medication |and |have |X |disease |/ |total |follow-up |(years) |of |the |patients |who |are
|receiving |the |new |medication |( |times |(x) |1000 |to |make |a |whole |number |if
|necessary) |(a/b |if |set |up |in |correct |way)
A |design |that |is |a |very |detailed |report |of |the |specific |features |of |a |particular
|participant |or |case |is |known |as? |- |correct |answer |case |report
The |Cumulative |incidence |is |computed |as |the |number |of |persons |who |develop |a
|disease |during |a |specified |period |over |the |number |of |persons |examined |at
|baseline |- |correct |answer |false
pf3
pf4
pf5
pf8

Partial preview of the text

Download Biostatistics Exercises and Questions: A Guide to Understanding Health Data and more Exams Nursing in PDF only on Docsity!

Which |of |the |following |types |of |graphics |would |be |most |useful |in |demonstrating |the |frequency |of |a |given |outcome |as |it |relates |to |an |ordinal |variable? |- |correct |answer |✔histogram 5 | 7 | 6 | 9 | 4 | 1 | 2 | 2 According |to |the |data, |which |measure, |is |a |better |measure |of |dispersion? |- |correct |answer |✔standard |deviation Misclassification |bias |often |occurs |in |case-control |studies. |- |correct |answer |✔True The |incidence |rate |of |X |disease |in |patients |receiving |the |new |medication |is |calculated |by: |- |correct |answer |✔patients |who |are |receiving |the |new |medication |and |have |X |disease |/ |total |follow-up |(years) |of |the |patients |who |are |receiving |the |new |medication |( |times |(x) | 1000 |to |make |a |whole |number |if |necessary) |(a/b |if |set |up |in |correct |way) A |design |that |is |a |very |detailed |report |of |the |specific |features |of |a |particular |participant |or |case |is |known |as? |- |correct |answer |✔case |report The |Cumulative |incidence |is |computed |as |the |number |of |persons |who |develop |a |disease |during |a |specified |period |over |the |number |of |persons |examined |at |baseline |- |correct |answer |✔false

1,000 |people |are |enrolled |in |a |10-year |cohort |study. |At |the |start |of |the |study, | 100 |have |diagnosed |CVD. |Over |the |course |of |the |study, | 80 |people |who |were |free |of |CVD |at |baseline |develop |CVD. |What |is |the |cumulative |incidence |at | 10 |years? |- |correct |answer |✔0.089 |= |80/900: |the |number |of |new |events |or |cases |of |disease |divided |by |the |total |number |of |individuals |in |the |population |at |risk |for |a |specific |time |interval. Biostatistics |is |integral |to |the |field |of |epidemiology, |which |is |defined |as |study |of |health |and |illness |in |human |populations, |patterns |of |health |or |disease, |and |the |factors |that |influence |these |patterns. |- |correct |answer |✔True The |best |numerical |summaries |for |dichotomous, |ordinal, |and |categorical |variables |are |relative |frequencies. |- |correct |answer |✔true Incidence |of |disease |is |the |proportion |of |individuals |with |the |condition |(disease) |at |a |single |point |in |time |- |correct |answer |✔false The |following |data |were |collected |as |part |of |a |study |of |coffee |consumption |among |graduate |students. |The |following |reflect |cups |per |day |consumed: |3, |4, |6, | 8 |,2, |1, |0, |and |2. |The |standard |deviation |is |approximately |4. |- |correct |answer |✔false: |use |excel |to |find |stdev(). Assume |a |new |measure |of |Intelligence |Quotient |(or |IQ) |has |been |developed. |The |mean |IQ |for |the |population |is | 100 |and |the |standard |deviation |is |15. |The |standard |deviation |indicates |the |average |distance |an |individual |data |value |is |from |the |mean |is |about | 15 |IQ |points. |- |correct |answer |✔true

Which |type |of |study |design |can |assess |temporal |relationship? |- |correct |answer |✔a |cohort |study A |fungal |meningitis |outbreak |has |been |traced |back |to |a |particular |compound |pharmacy |selling |a |specific |injectable |drug |that |is |suspected |to |have |been |contaminated. |In |the |past | 4 |weeks |15,051 |patients |were |given |the |medication, |and |of |those |patients | 72 |individuals |contracted |fungal |meningitis. |What |is |the |cumulative |incidence |for |meningitis |among |those |individuals |who |the |medication |was |administered |to? |- |correct |answer |✔cumulative |incidence: |the |number |of |new |events |or |cases |of |disease |divided |by |the |total |number |of |individuals |in |the |population |at |risk |for |a |specific |time |interval. =72/15051 |=> |0.0048. Two |types |of |medical |devices |used |for |knee |replacement |are |being |studied |to |see |if |the |type |of |knee |replacement |used |affects |the |rate |of |infection |for |a |specific |bacterial |infection. |The |infection |rate |for |a |specific |bacterial |infection |after |surgery |for |device |A |is |0.0043. |The |rate |for |the |same |bacterial |infection |is |0.0121 |for |device |B. |How |does |the |risk |of |developing |the |bacterial |infection |in |individuals |using |device |B |compare |to |the |risk |of |developing |the |bacterial |infection |in |individuals |using |device |A? |- |correct |answer |✔Individuals |using |device |B |are |2.814 |(.0121/.0043) |times |more |likely |to |develop |the |bacterial |infection |of |interest |than |individuals |using |device |A. The |best |measure |of |central |tendency |for |systolic |blood |pressure |readings |obtained |from |a |population |of | 7 |individuals |whose |systolic |blood |pressure |readings |were |101, |104, |108, |109, |111, |112, |and | 160 |is |the |mean. |- |correct |answer |✔false

Understanding |biostatistical |principles |is |critical |to |public |health |education. |- |correct |answer |✔true The |following |data |were |collected |as |part |of |a |study |of |tea |consumption |among |undergraduate |students |in |England. |The |following |reflect |cups |per |day |consumed: 5 | 7 | 6 | 9 | 4 | 1 | 2 | 2 According |to |the |data |the |median |is: |- |correct |answer |✔4. The |mean |is |the |best |measure |of |typical |value |(central |tendency) |when |they |are |outliers |present |in |the |data. |- |correct |answer |✔false The |applicability |of |the |research |results |to |a |specific |population |obtained |from |a |biostatistics |study |is |best |determined |by |which |of |the |following? |- |correct |answer |✔The |inclusion |and |exclusion |criteria |of |the |study. Confounding |is |usually |a |major |issue |in |cohort |studies |- |correct |answer |✔True The |most |appropriate |study |design |depends, |among |other |things, |on |the |distribution |of |- |correct |answer |✔The |risk |factor |in |the |population |of |interest |& |The |outcome |in |the |population |of |interest What |is |the |incidence |rate |of |coronary |artery |disease |in |patients |receiving |placebo |approximately: | Info |given: |placebo |+ |coronary |artery |disease |= |28. |Total |follow-up |(years) |+ |placebo |= | 2750 |- |correct |answer |✔28/2750 |= |0.01018 |x | 1000 |=> | 10 |per | 1000 |person-years.

Odds |ratio |can |be |used |to |approximate |the |relative |risk |when |the |disease |under |study |is |rare. |- |correct |answer |✔true The |proportion |of |the |sample |with |disease |is |computed |by |taking |the |ratio |of |the |number |with |disease |to |the |total |sample |size. |- |correct |answer |✔true Calculate |the |lower |quartile |of |the |data |set |for |the |blood |glucose |levels |of | 10 |individuals |whose |blood |glucose |readings |were |as |follows: |88, |97, |101, |104, |104, |107, |109, |117, |121, |and |147. |- |correct |answer |✔101.0 |in |excel: |"=QUARTILE(A1:A10,1)" |or |for |third |quartile: |"=QUARTILE(A1:A10,3)" Risk |difference |may |sometimes |be |referred |to |as |excess |risk. |- |correct |answer |✔True Confounding |is |the |major |issue |in |clinical |trials. |- |correct |answer |✔false Two |thousand |are |enrolled |in |a |20-year |cohort |study. |At |the |start |of |the |study, |No |one |was |diagnosed |with |cardiovascular |disease. |Over |the |course |of |the |study, | 100 |people |who |were |free |of |cardiovascular |disease |at |baseline |develop |cardiovascular |disease. |The |prevalence |of |cardiovascular |disease |at |baseline |is |0. |- |correct |answer |✔True: |Prevalence |= |?the |proportion |of |persons |in |a |population |who |have |a |particular |disease |or |attribute |at |a |specified |point |in |time |or |over |a |specified |period |of |time.? What |is |the |ideal |study |design |from |a |statistical |point |of |view? |- |correct |answer |✔Clinical |trial

In |a |study |measuring |the |frequency |of |pain |scores |of |patients |on |a |scale |from | 1 |to | 10 |for |a |specific |type |of |pain |relief |therapy, |the |pain |score |variable |would |best |be |described |as |which |type |of |variable? |- |correct |answer |✔ordinal |variable Five |hundred |people |are |enrolled |in |a |10-year |cohort |study. |At |the |start |of |the |study, | 50 |have |diagnosed |CVD. |Over |the |course |of |the |study, | 40 |people |who |were |free |of |CVD |at |baseline |develop |CVD. |The |prevalence |of |CVD |at | 10 |years |is |10% |- |correct |answer |✔false Among |individuals |who |eat |a |healthy |diet |and |exercise |frequently |the |point |prevalence |of |hypertension |is |0.09. |Individuals |subject |to |poverty, |making |it |more |difficult |for |them |to |eat |a |healthy |diet |and |exercise |frequently, |have |a |0.31 |point |prevalence |for |hypertension. |What |is |the |risk |difference |between |the |two |groups? |- |correct |answer |✔.22: |risk |difference |= |difference |in |point |prevalence, |cumulative |incidence, |or |incidence |rates |(PP,ex |- |PP,unex |/ |CI,ex |- |CI,unex |/ |IR,ex |- |IR,unex) |= |.31 |- |.09 |= |. Race |is |an |example |of |which |type |of |variable? |- |correct |answer |✔categorical |variable Calculate |the |mean |blood |glucose |level |for |a |study |measuring |the |blood |glucose |levels |of | 10 |individuals |whose |blood |glucose |readings |were |as |follows: |88, |97, |101, |104, |104, |107, |109, |117, |121, |and |147. |- |correct |answer |✔109. Calculate |the |point |prevalence |for |Alzheimer's |disease |among |individuals | 65 |years |of |age |or |older |in |a |county |that |has |200,000 |individuals |who |are | 65 |years |of |age |or |older, |if |22,223 |individuals |who |are | 65 |years |of |age |or |older |have |the |disease. |- |correct |answer |✔.1111 |: |PP |= |# |of |ppl |with |disease |/ |# |of |ppl |examined |a |baseline: |22,223/200,000 |= |.